Current State of Fluid Lipid Biomarkers for Personalized Diagnostics and Therapeutics in Schizophrenia Spectrum Disorders and Related Psychoses: A Narrative Review
Schizophrenia spectrum disorders (SSD) are traditionally diagnosed and categorized through clinical assessment, owing to their complex heterogeneity and an insufficient understanding of their underlying pathology. However, disease progression and accurate clinical diagnosis become problematic when d...
Main Authors: | Timothy A. Couttas, Beverly Jieu, Cathrin Rohleder, F. Markus Leweke |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-05-01
|
Series: | Frontiers in Psychiatry |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fpsyt.2022.885904/full |
Similar Items
-
Sleep Disturbances in At-Risk Mental States and First Episode of Psychosis: A Narrative Review on Interventions
by: Lorena Marin, et al.
Published: (2023-04-01) -
Growth in the Aftermath of Psychosis: Characterizing Post-traumatic Growth in Persons With First Episode Psychosis in Singapore
by: Ying Ying Lee, et al.
Published: (2022-01-01) -
Cannabidiol enhances cerebral glucose utilization and ameliorates psychopathology and cognition: A case report in a clinically high-risk mental state
by: Dagmar Koethe, et al.
Published: (2023-03-01) -
Subjective cognitive complaints in first episode psychosis: A focused follow-up on sex effect and alcohol usage
by: E. Stip, et al.
Published: (2022-12-01) -
ReTimeML: a retention time predictor that supports the LC–MS/MS analysis of sphingolipids
by: Michael Allwright, et al.
Published: (2024-02-01)